Dopavision

Description: Dopavision develops a smartphone-based digital therapeutic (MyopiaX®) to treat childhood myopia by targeting retinal dopamine, addressing a global vision crisis.

Country: Germany

Based in: Berlin

Founded: 2017

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Health Care', 'Medical Device', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.